Cancer
Access to Innovation: Beyond a ‘pharma-only’ approach
October 19, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, ecco, oncology
Peter Naredi, of ECCO, explores how a multi-dimensional approach is necessary to ensure that patients receive access to the most …
Lilly teams up with CureVac in $1.8 billion cancer vaccine partnership
October 19, 2017Research and Development, Sales and Marketing Cancer, CureVac, Eli Lilly, Vaccine
Eli Lilly has announced it is to partner up with CureVac to leverage its proprietary RNActive technology in order to …
First-ever study in the personalised treatment of rare cancers brings promising results
October 18, 2017Research and Development Cancer, Cancer Research UK, personalised medicine, pharma, rare cancer
The first-ever trial to treat patients for rare cancers in a personalised manner based on the characteristics of their individual …
AstraZeneca lung cancer drug proves able to shrink EGFR mutation-positive tumours
October 17, 2017Manufacturing and Production, Research and Development AstraZeneca, Cancer, Chi-Med, lung cancer, pharma, savolitinib
AstraZeneca and its partner Hutchison China MedTech, also known as Chi-Med, have announced positive data for savolitinib in combination with …
EMA responds to criticism of its cancer drug approvals
October 17, 2017Manufacturing and Production, Medical Communications Cancer, EMA, biotech, drugs, oncology, pharma, pharmaceutical
The EMA received a broadside just less than two week ago from a group of researchers that had studied data …
NICE gives final draft guidance on two key cancer drugs
October 12, 2017Sales and Marketing Bayer, CDF, Cancer, Cancer Drugs Fund, Erivedge, NICE, Roche, Stivarga
NICE has announced it has published its final draft guidance for two cancer treatments, covering Bayer’s Stivarga (regorafenib) in the …
Moffitt scientists discover new applications for Novartis’s Zykadia
October 11, 2017Research and Development Cancer, Moffitt, NSCLC, ceritinib, lung cancer, zykadia
Through the use of molecular screening, functional proteomics and computer-based modelling, researchers from the Moffitt Cancer Center have been working …
Harnessing the power of the immune system
October 9, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, Cancer Research UK, immunotherapy, pharma, pharmaceuticals
Dr Áine McCarthy, Senior Science Information Officer at Cancer Research UK, discusses the latest efforts to further understand the immunotherapies …
AstraZeneca’s Tagrisso secures Breakthrough Therapy Designation in first-line NSCLC
October 9, 2017Sales and Marketing AstraZeneca, Cancer, NSCLC, immunotherapy, lung cancer
AstraZeneca has announced that its targeted therapy, Tagrisso (osimertinib), has been awarded Breakthrough Therapy Designation by the FDA for the …
Overcoming real-world challenges to maximise the benefit of treatment for patients with multiple myeloma
October 2, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, Takeda, multiple myeloma
Dr Antonio Palumbo, Distinguished Research Fellow Oncology, Takeda Pharmaceuticals addresses hwo far we’ve come in treating multiple myeloma, and how …
FDA awards Roche priority review in HER2-positive breast cancer
October 2, 2017Sales and Marketing Cancer, FDA, Herceptin, Perjeta, Roche, breast cancer, pharma, pharmaceutical
Roche has revealed that its monoclonal antibody Perjeta (pertuzumab) has been awarded priority review by the FDA as an adjuvant …
Roche’s Tecentriq scores approvals in metastatic lung and bladder cancer
September 27, 2017Research and Development, Sales and Marketing Cancer, EMA, EU, European Commission, Roche, bladder cancer, immunotherapy, lung cancer, pharma, tecentriq
It’s good news for Roche as the company’s immunotherapy drug Tecentriq secures approval from the European Commission to be used …
Merck and Pfizer’s joint skin cancer drug gets EU approval
September 21, 2017Sales and Marketing Bavencio, Cancer, Merck, Pfizer, merkel cell carcinoma, pharma, pharmaceutical, skin canceer
Merck KGaA and Pfizer have announced that European authorisation of their jointly developed drug Bavencio (avelumab) as a monotherapy in …
FDA approves first-ever biosimilar for cancer treatment
September 15, 2017Medical Communications, Sales and Marketing Amgen, Cancer, FDA, Mvasi, avastin, biosimilar
The FDA has announced the news that it has awarded approval to the first-ever biosimilar for the treatment of cancer …
New ‘pen’ device identifies cancerous tissue in just ten seconds
September 7, 2017Research and Development Cancer, University of Texas, digital, medicine, pharma, pharmaceutical, tumour
Scientists at the Baylor College of Medicine, University of Texas have developed a device which they claim can identify cancerous …
Latest content
AstraZeneca’s Trixeo approved in EU for asthma
ESTEVE CDMO adds $17.5m to Illinois expansion
